SiteOne Therapeutics logo

SiteOne Therapeutics Funding & Investors

Bozeman, MT

SiteOne Therapeutics is a clinical-stage biopharmaceutical company developing therapeutics for the treatment of hypersensitivity disorders such as chronic cough, itch, and pain.

siteonetherapeutics.com

Total Amount Raised: $134,178,360

SiteOne Therapeutics Funding Rounds

  • Series C

    $100,000,000

    Series C Investors

    Novo Holdings
    BSQUARED Capital
    OrbiMed Advisors
    Mission BioCapital
    Wellington Management

  • Grant

    $15,000,000

    Grant Investors

    National Institute on Drug Abuse (NIDA)

  • Series B

    $15,000,000

    Series B Investors

    Amgen
    Next Frontier Capital
    2M Companies
    Mission Bay Capital
    Sears Capital Management
    Z Investments
    BIOBRIT
    Mission BioCapital

  • Series Unknown

    $1,278,358

    Series Unknown Investors

    Next Frontier Capital
    Sears Capital Management
    Mission Bay Capital
    BIOBRIT

  • Series A

    $1,500,000

    Series A Investors

    Sears Capital Management
    Bay Capital
    BIOBRIT
    Joe Zakrzewski

  • Grant

    $1,400,000

Funding info provided by Diffbot.